SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Vascular Biogenics Ltd. (VBLT)

VBLT RSS Feed
Add VBLT Price Alert      Hide Sticky   Hide Intro
Moderator: gr8db8
Search This Board: 
Last Post: 12/7/2017 1:05:23 PM - Followers: 42 - Board type: Free - Posts Today: 0

Vascular Biogenics Ltd is an Israel-based clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of treatments for cancer and immune-inflammatory diseases. Its clinical pipeline is based on two platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. As of June 6, 2014, it has developed two programs based on these platforms an oncology program and an anti-inflammatory program. Its lead product candidate from its oncology program, VB-111, is a gene-based biologic that is initially developing for recurrent glioblastoma (rGBM), an aggressive form of brain cancer. The Company has also received orphan drug designation in both the United States and Europe. The Company’s oncology program is based on its Vascular Targeting System (VTS), platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. http://www.vblrx.com
SureTrader
Interactive Brokers Advertisement
VBLT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
VBLT News: Report of Foreign Issuer (6-k) 11/21/2017 04:07:19 PM
VBLT News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 11/20/2017 05:18:37 PM
VBLT News: Report of Foreign Issuer (6-k) 11/20/2017 05:14:41 PM
VBLT News: VBL Therapeutics Prices  2.5 Million Ordinary Share Offering 11/17/2017 09:00:00 AM
VBLT News: Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp) 11/16/2017 05:15:46 PM
PostSubject
#1711   http://www.massdevice.com/novocure-touts-jama-pub-of-optune-trail-data/ Try tha Jumpinjackas 12/06/17 02:05:41 PM
#1710   Good question ? Maybe it has something to do mjw007 12/06/17 02:03:13 PM
#1709   Many doctors doubt optune. They think it doesn't Oren1976 12/06/17 11:14:47 AM
#1708   Optunes trial was halted by data safety montioring Jumpinjackas 12/06/17 05:45:02 AM
#1707   There is similarity between optune and vb111 and Oren1976 12/06/17 03:15:28 AM
#1706   There was conditional approval and now it's just Oren1976 12/05/17 07:30:55 PM
#1705   Avastin is like the old generation drugs that Oren1976 12/05/17 07:16:28 PM
#1704   What’s your take on this? I thought MF82 12/05/17 07:14:44 PM
#1703   I don't know if this is the reason. Oren1976 12/05/17 07:10:58 PM
#1702   Oren- what do you make of this? MF82 12/05/17 06:08:50 PM
#1701   I listened to the webcast (did more of SCHB 11/30/17 02:53:13 PM
#1700   TA on VBLT tpizzazz24 11/29/17 04:14:58 PM
#1699   It was very personal there. I think Oren1976 11/29/17 10:29:40 AM
#1698   Imminent like end of Q1? Jumpinjackas 11/29/17 05:03:04 AM
#1697   Corect We should wait and see if it happens... mazlat10 11/29/17 04:06:18 AM
#1696   The article from bottom to top gives the Oren1976 11/28/17 12:21:22 PM
#1695   The article is quite informal and was published mantoo123 11/28/17 10:35:41 AM
#1694   It is great to have people who can wcopeland 11/28/17 10:19:40 AM
#1693   I read the article in Hebrew without Google mantoo123 11/28/17 03:06:18 AM
#1692   I think there's a big difference between a SCHB 11/28/17 12:53:54 AM
#1691   The market valuation of vbl is exactly as Oren1976 11/28/17 12:08:29 AM
#1690   You used translator but I am native Hebrew Oren1976 11/27/17 11:45:37 PM
#1689   Thanks for the link. I read the article gr8db8 11/27/17 11:33:05 PM
#1688   an interview from 22nov with Dr Erez Feige Oren1976 11/27/17 11:03:00 PM
#1687   Regarding survival data for PrOC. wcopeland 11/25/17 02:29:18 PM
#1686   Thanks again for the detailed analysis. In the SCHB 11/25/17 02:23:36 PM
#1685   Comparing 17 vs. 4 is not statistically rigorous. wcopeland 11/25/17 01:55:42 PM
#1684   The reason for the Forbes writer and AF's SCHB 11/25/17 01:33:46 PM
#1683   I don't think most investors look at the mantoo123 11/25/17 05:54:50 AM
#1682   Another 5 months have gone by since Asco staccani 11/25/17 12:10:53 AM
#1681   staccani 11/24/17 11:56:07 PM
#1680   Here u said different thing. Here u said Oren1976 11/24/17 09:43:52 PM
#1679   Could it u both right ? At the Oren1976 11/24/17 07:27:04 PM
#1678   I look at the chart and the 9th Oren1976 11/24/17 07:23:09 PM
#1677   THANK YOU, wcopeland, for bringing some clarity/sanity to gr8db8 11/24/17 07:12:16 PM
#1676   And I tell you one more thing. In staccani 11/24/17 06:36:45 PM
#1675   This is a joke. If 9 patients staccani 11/24/17 05:21:43 PM
#1674   Thank u for repeating the explanation from back Oren1976 11/24/17 05:06:19 PM
#1673   Why do you people continue to listen to wcopeland 11/24/17 04:30:33 PM
#1672   Thanks Oren, I see that now on slide SCHB 11/24/17 02:59:57 PM
#1671   I suggest u read past threads . If Oren1976 11/24/17 02:20:39 PM
#1670   Can you point to me where they stated SCHB 11/24/17 02:16:23 PM
#1669   yes I agree, ph3 results will not lie staccani 11/24/17 02:12:15 PM
#1668   The info u show prove they lie unless Oren1976 11/24/17 01:58:54 PM
#1667   Look at their latest presentation (sept 2017), page staccani 11/24/17 01:38:44 PM
#1666   About the gbm they moved to speak 59 Oren1976 11/24/17 01:24:22 PM
#1665   I think with those numbers they would still staccani 11/24/17 12:54:31 PM
#1664   Let's presume, staccani, that they are being dishonest SCHB 11/24/17 12:50:12 PM
#1663   As for dilution he is doing what most staccani 11/24/17 12:41:59 PM
#1662   VBLT buy 6.9117 stocktrademan 11/24/17 12:02:45 PM
PostSubject